Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.
Science Translational Medicine.
Times cited: 100
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.
Journal of Thoracic Oncology.
Times cited: 52
Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.
Clinical Cancer Research.
Times cited: 127